A detailed history of Tower Research Capital LLC (Trc) transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,989 shares of ABEO stock, worth $34,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,989
Previous 37,977 84.23%
Holding current value
$34,137
Previous $161,000 77.02%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.12 - $6.32 $131,790 - $202,164
-31,988 Reduced 84.23%
5,989 $37,000
Q2 2024

Aug 13, 2024

BUY
$3.17 - $8.05 $69,223 - $175,787
21,837 Added 135.3%
37,977 $161,000
Q1 2024

May 15, 2024

BUY
$4.07 - $8.68 $57,492 - $122,613
14,126 Added 701.39%
16,140 $117,000
Q4 2023

Feb 13, 2024

SELL
$3.71 - $5.14 $30,818 - $42,697
-8,307 Reduced 80.49%
2,014 $10,000
Q3 2023

Nov 14, 2023

BUY
$2.98 - $4.43 $30,756 - $45,722
10,321 New
10,321 $43,000
Q1 2023

May 09, 2023

SELL
$2.25 - $3.27 $36,099 - $52,463
-16,044 Reduced 96.16%
640 $2,000
Q4 2022

Feb 10, 2023

BUY
$2.4 - $5.65 $39,304 - $92,530
16,377 Added 5334.53%
16,684 $52,000
Q3 2022

Nov 10, 2022

BUY
$2.79 - $5.56 $856 - $1,706
307 New
307 $1,000

Others Institutions Holding ABEO

About ABEONA THERAPEUTICS INC.


  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $33.9M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.